Home / DGKH Knockout Cell Lines

DGKH Knockout Cell Lines

Gene: DGKH

Official Full Name: diacylglycerol kinase etaprovided by HGNC

Gene Summary: This gene encodes a member of the diacylglycerol kinase (DGK) enzyme family. Members of this family are involved in regulating intracellular concentrations of diacylglycerol and phosphatidic acid. Variation in this gene has been associated with bipolar disorder. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2014]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO07768 DGKH Knockout cell line (HeLa) Human DGKH 1:3~1:6 Negative Online Inquiry
KO07769 DGKH Knockout cell line (HCT 116) Human DGKH 1:2~1:4 Negative Online Inquiry
KO07770 DGKH Knockout cell line (HEK293) Human DGKH 1:3~1:6 Negative Online Inquiry
KO07771 DGKH Knockout cell line (A549) Human DGKH 1:3~1:4 Negative Online Inquiry

Background

DGKH Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the diacylglycerol kinase delta (DGKH) gene. This gene plays a critical role in lipid signaling, influencing various cellular processes including differentiation, proliferation, and apoptosis. By offering these knockout cell lines, researchers can directly study the implications of DGKH absence in cellular function, signaling pathways, and disease states, leading to a deeper understanding of its role in critical biological processes.

The primary function of DGKH is to catalyze the conversion of diacylglycerol (DAG) into phosphatidic acid, thereby regulating levels of DAG, which is a key second messenger in various cellular signaling pathways, including those involved in inflammation and neurobiology. The DGKH gene knockout models provide a unique experimental setup to elucidate the functional consequences of DGKH loss, allowing researchers to emulate disease conditions where DGKH dysregulation may occur.

The scientific importance of these cell lines extends to both research and clinical applications, particularly in the fields of cancer, neurodegeneration, and metabolic diseases. By utilizing DGKH knockout models, scientists can investigate the underlying molecular mechanisms associated with these conditions, potentially identifying novel therapeutic targets or biomarkers for disease progression.

One of the unique selling points of our DGKH Gene Knockout Cell Lines is the precision and reliability of the gene knockout achieved through state-of-the-art CRISPR/Cas9 technology. This specificity minimizes off-target effects, ensuring that researchers obtain reproducible and accurate results. Compared to alternative models, our cell lines are optimized for performance in a variety of assays, from cell viability to drug response studies.

The value of DGKH Gene Knockout Cell Lines to researchers and clinicians lies in their ability to enhance the understanding of DGKH-associated pathways and their implications in health and disease. This can pave the way for innovative therapeutic strategies and interventions, making these cell lines an indispensable tool in contemporary biological research.

Our company specializes in providing high-quality, genetically modified cell lines tailored to meet the needs of the scientific community. With extensive expertise in gene editing and cellular biology, we are committed to supporting researchers with reliable products that advance their studies and contribute to the broader field of health sciences.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.